COVID-19 Vaccination

Last updated 14th April 2021

Myhealth Hampton and Myhealth Mentone are approved COVID-19 vaccination centres. The commencement dates and vaccine sessions will be subject to guidelines on distribution

Myhealth Hampton and Myhealth Mentone are now accepting bookings for COVID-19 vaccination. If you cannot book at a suitable time, please check back after a few days as we will continually open further vaccination sessions according to demand and staffing.

This web page is solely for accessing the COVID-19 vaccine at Myhealth Hampton or Myhealth Mentone.

For all other matters, please visit our main web pages at Hampton or Mentone

Before you may receive your vaccine, there are a number of steps to be undertaken.

STEP 1 – Preliminary Tasks

You must have a valid Medicare number in order for you to receive the vaccine at our practice. If you are an overseas visitor and do not have a Medicare number, you are still eligible to receive the vaccine but via other avenues.

Information for DVA Care holders
  • If you have a Veteran Gold Card, bring that. 
  • If you have a Veteran White Card, bring your Medicare card as well. 
  • If you have a Veteran Orange Card, just bring your Medicare card. 
  • If you don’t have a Medicare card and you don’t know your Medicare number, phone Medicare on 132 011. 
  • If you don’t have a Medicare number, you can still get the COVID-19 vaccine. We recommend you call Medicare on 132 011 first, to check you are not enrolled with Medicare already. The staff member will help you to either enrol in Medicare or to apply for an Individual Healthcare Identifier (IHI) if you don’t already have one.
  • Even if you are not in Medicare, you will have an IHI if you get a DVA pension or benefit.

People who are not eligible for Medicare, for example a temporary resident, will need to attend a state- or territory-run vaccination clinic to get their COVID-19 vaccines. 

You can find more information about getting an IHI at https://servicesaustralia.gov.au/ihs on the Services Australia website. 

More information about this is below:

Services Australia – Get Ready for Your COVID-19 Vaccinations
https://www.servicesaustralia.gov.au/individuals/news/get-ready-your-covid-19-vaccinations

What Should I Do Before I Get Vaccinated for COVID-19 ?
https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/learn-about-covid-19-vaccines/what-should-i-do-before-i-get-vaccinated-for-covid-19

STEP 2 – Check Your Eligibility for the Vaccine

Vaccine Eligibility Checker

Check to see if you are eligible to receive the vaccine now. COVID-19 vaccines will be available in phases. Groups of people get the vaccination at different times.

The groups are Phase 1a, Phase 1b, Phase 2a, Phase 2b and Phase 3.

Eligible patients for Phase 1b include the following:

All patients over the age of 70

Aboriginal or Torres Strait Islanders over the age of 55

Healthcare workers, Aged Care Workers and Disability Workers

Critical and high risk workers

  • Emergency services personnel- police officers, fire and rescue personnel, corrective services officers
  • Rural Fire Service and State Emergency Service volunteers
  • Active Australian Defence Force personnel
  • Australian Government officials
  • Workers involved in manufacture of AstraZeneca vaccine and distribution/delivery of COVID-19 vaccines
  • Workers at licensed meat processing businesses
  • Household contacts of quarantine and border workers
  • People with disability attending centre-based services such as: day programs, respite care, supported employment

Patients aged 18 to 69 with a valid chronic health condition as below

Immunocompromising conditionsNotes
Solid organ transplant recipients who are on immune suppressive therapy
Bone marrow transplant OR chimeric antigen receptor T-cell (CAR-T) therapy recipients OR those with graft versus host disease
Haematological diseases or cancersIncluding leukaemia, lymphoma or myeloma resulting in immunocompromise
Non-haematological cancersDiagnosed within the past 5 years OR on chemotherapy, radiotherapy, immunotherapy or targeted anti-cancer therapy (active treatment or recently completed) OR with advanced disease regardless of treatment
Adult survivors of childhood cancers
Chronic inflammatory conditions on medical treatmentsIncluding: Systemic Lupus Erythematosus, Rheumatoid Arthritis, Crohn’s disease, ulcerative colitis, and similar who are being treated with Disease modifying anti-rheumatic drugs (DMARDs) or immune-suppressive or immunomodulatory therapies. 
Generally not inclusive of people living with osteoarthritis, fibromyalgia, myalgicencephalomyelitis/chronic fatigue syndrome or similar non-immunocompromising inflammatory conditions.
Primary or acquired immunodeficiencyIncluding congenital causes of immunodeficiency and HIV/AIDS
Other underlying conditionsNotes
Chronic renal (kidney) failure with eGFR of ≥ 44ml/minDoes not include mild-moderate chronic kidney disease
Heart diseaseIncluding Ischaemic heart disease, valvular heart disease, cardiomyopathies and pulmonary hypertension
Chronic lung diseaseIncluding Chronic Obstructive Pulmonary Disease, cystic fibrosis, interstitial lung disease.  Does not include Mild or moderate asthma
Diabetes
Severe obesity with a BMI ≥ 40kg/m2
Chronic liver disease
Some neurological conditionsIncluding Stroke, dementia, Multiple sclerosis, motor neurone disease, Parkinson’s disease, cerebral palsy.
Generally not inclusive of migraine or cluster headaches
Poorly controlled blood pressureDefined as two or more pharmacologic agents for blood pressure control, regardless of recent readings
Those living with significant disability requiring frequent assistance with activities of daily livingIncluding Down Syndrome, muscular dystrophy, traumatic brain and spinal cord injury, severe intellectual disability
Those with severe mental health conditionsIncluding schizophrenia, bi-polar disorder affecting ability to adhere to public health measures

Learn more about the vaccination phases and eligibility

Priority groups for COVID-19 Vaccination Program: Phase 1b

STEP 3 – Vaccine Information and Consent

This step asks you to read about potential side effects of the vaccine and to discuss with your usual doctor about any safety or side-effect concerns that you may have.

People who have a COVID-19 vaccination have a much lower chance of getting sick from the disease called COVID-19.

The COVID-19 vaccination is free. You choose to have the vaccination or not.

To be vaccinated you will get a needle in your arm. You need to have the vaccination two times on different days. There are different brands of vaccine. You need to have the same brand of vaccine both times.

We are providing the AstraZeneca vaccine which requires TWO doses , 12 weeks apart.

Please note that our clinics currently do not hold any stock of the Pfizer vaccine

COVID-19 Vaccine consent form
It is not crucial for this form to be signed but is recommended if the person receiving the vaccine cannot provide verbal consent on their own behalf ( eg dementia or intellectual disability patients)

Information on this form is relevant to your understanding of the vaccine.
https://www.health.gov.au/resources/publications/covid-19-vaccination-consent-form-for-covid-19-vaccination

About the vaccine

COVID-19 Vaccine AstraZeneca can prevent people from becoming ill from COVID-19. This vaccine does not contain any live SARS-CoV-2 virus, and cannot give you COVID-19. It contains the genetic code for an important part of the SARS-CoV-2 virus called the spike protein. This code is inserted into a harmless common cold virus (an adenovirus), which brings it into your cells. Your body then makes copies of the spike protein, and your immune system learns to recognise and fight the SARS-CoV-2 virus. The adenovirus has been modified so that it cannot replicate once it is inside cells. This means it cannot spread to other cells and cause infection. 

Vaccination is voluntary and free. You can discuss any concerns or questions you have about COVID-19 vaccination with your immunisation provider and/or your GP before you receive the vaccine.

COVID-19 Vaccine AstraZeneca can be used in people aged 18 and above, and is safe and effective. A very rare side effect reported after the AstraZeneca vaccine is ‘thrombosis with thrombocytopenia syndrome’ (TTS), which involves blood clotting and low blood platelet levels. The benefits of vaccination greatly outweigh the risk of this condition. However, to minimise this risk, Comirnaty (Pfizer) is the preferred COVID-19 vaccine for adults under 50 years of age, and for people with a past history of cerebral venous sinus thrombosis (a type of brain clot) or heparin induced thrombocytopenia (a rare reaction to heparin treatment).   

Benefits of vaccination

COVID-19 Vaccine AstraZeneca protects people from becoming ill from COVID-19. It particularly prevents severe illness, hospitalisation and death. The vaccine has been shown to be highly effective in both clinical trials (before it was registered for use) and in studies of people vaccinated in the ‘real world’ in England and Scotland. 

COVID-19 is a very serious disease which can cause serious illness in people of all ages. It has caused millions of deaths and hundreds of millions of infections worldwide. 

Vaccination helps protect both individual people and also benefits all people in the community by reducing the spread of COVID-19. 

Risks of vaccination

As with any vaccine, you may have some temporary side effects after receiving a COVID-19 vaccine. Common side effects after COVID-19 Vaccine AstraZeneca include: injection site pain or tenderness, tiredness, headache, muscle pain, and fever and chills Most side effects are mild and temporary, going away within 1-2 days. As with any medicine or vaccine, there may be rare and/or unknown side effects.

As with any medicine or vaccine, there may be rare and/or unknown side effects.

Thrombosis with thrombocytopenia syndrome (TTS)

COVID-19 Vaccine AstraZeneca appears to be associated with a rare side effect called thrombosis with thrombocytopenia syndrome (TTS), which has been reported in several countries overseas. 

What is TTS?

TTS involves blood clots (thrombosis) and low levels of blood platelets (thrombocytopenia), and occurs about 4-20 days after vaccination. The blood clots can occur in different parts of the body, such as the brain (called cerebral venous sinus thrombosis or CVST) or in the abdomen. 

The mechanism that causes TTS is not fully understood, but it appears similar to heparin-induced thrombocytopenia (or HIT), a rare reaction to heparin treatment. 

How common is TTS?

TTS is very rare (4-6 cases per million doses), but it can make people very unwell and in about 1 in 4 cases has led to death. As at 8 April one case and one probable (likely) case has been reported in Australia on 1 April 2020, following administration of approximately 400,000 doses of COVID-19 Vaccine AstraZeneca.  

Are any groups more at risk of TTS?

No specific risk factors have been confirmed for TTS. 

In the countries that have reported TTS, more cases have occurred in adults under 60 years of age compared to older adults, and in women compared to men. However it is not yet clear if age and sex are risk factors, since the AstraZeneca vaccine was preferentially given to younger people in some countries, and since women make up a large proportion of the healthcare workers that were prioritised for vaccination.

As a precaution, in Australia Comirnaty (Pfizer) vaccine is preferred for adults under 50 years of age, since their risk of TTS may be slightly higher than older people, and since they have a lower risk of severe outcomes from COVID-19 compared to older adults. 

Is the AstraZeneca vaccine safe in people who have had blood clots in the past?

Comirnaty (Pfizer) vaccine is preferred in people who have a past history of cerebral venous sinus thrombosis or heparin-induced thrombocytopenia, given the similarities between these conditions at TTS. 

If you have had other types of blood clots in the past, or if you have risk factors for blood clots, you can still have the AstraZeneca vaccine. There is no evidence that people who have had a past history of other types of blood clots have an increased risk of TTS. The overall rate of blood clots has not risen in countries which have extensively used the AstraZeneca vaccine. 

What if I have had my first dose of AstraZeneca vaccine?

All of the cases of TTS reported to date have occurred after the first dose of the vaccine. People who have had their first dose without any serious side effects can be confident in getting their second dose. 

What symptoms does thrombosis with thrombocytopenia syndrome usually cause?

TTS is very rare and occurs around 4-20 days after vaccination. Symptoms can include abdominal pain and/or severe headache that does not settle with pain relief.

People should seek medical attention immediately if they experience these symptoms:

  • a severe persistent headache with additional features:
    • appears at least 4 days after vaccination
    • does not improve with simple painkillers
    • may be worse when lying down or accompanied by nausea and vomiting
  • neurological symptoms such as:
    • blurred vision 
    • difficulty with speech
    • drowsiness 
    • seizures 
  • shortness of breath or chest pain
  • a swollen leg
  • persistent abdominal (belly) pain
  • tiny blood spots under the skin away from the site of injection together with symptoms above.

Things to consider before vaccination

Precautions

People with certain conditions may need additional precautions such as staying for 30 minutes of observation after having their vaccine or consulting an allergy specialist. Tell your immunisation provider if you have had:

  • an allergic reaction to a previous dose of a COVID-19 vaccine or to an ingredient of the vaccine
  • anaphylaxis to other vaccines or to other medicines. Your provider can check to ensure there are no common ingredients with the COVID-19 vaccine you are receiving
  • mast cell disorder

If you have a bleeding disorder or you are taking a blood-thinning medication (anticoagulant), tell your immunisation provider. Your provider can help determine whether it is safe for you to have an intramuscular injection, and help to decide the best timing for injection. 

People with weakened immune systems (immunocompromise)

People with immunocompromise includes those who have a medical condition or are taking medications that weaken their immune system. People with immunocompromise, including those living with HIV, have a higher risk of severe illness from COVID-19, including a higher risk of severe illness and death.

The Australian Government strongly recommends people with immunocompromise receive a COVID-19 vaccine. COVID-19 Vaccine AstraZeneca does not behave like a ‘live vaccine’. The adenovirus carrier has been modified so that it cannot replicate or spread to other cells, and it cannot cause infection. It is safe in people with immunocompromise.

Clinical trials for COVID-19 Vaccine AstraZeneca did not include people with immunocompromised but many people with such conditions have now been vaccinated worldwide. A clinical trial is being conducted of COVID-19 Vaccine AstraZeneca given to people with stable HIV infection, with results expected in a few months. 

We do not know if COVID-19 Vaccine AstraZeneca is as effective in people with immunocompromise compared to the rest of the population. It is possible that it might be less effective, and so it is important to continue other preventative measures such as physical distancing after vaccination. 

For more information on use of the vaccine in immunocompromised see: COVID-19 vaccination decision guide for people with immunocompromised. (https://www.health.gov.au/resources/publications/atagi-covid-19-vaccination-decision-guide-for-people-with-immunocompromise )

Women who are pregnant or breastfeeding

If you are breastfeeding, it is preferable for you to have the Pfizer (Comirnaty) COVID-19 vaccine. This is the preferred vaccine in young adults. However, you can still have the COVID-19 Vaccine AstraZeneca if the benefits of vaccination outweigh the risks for you. You do not need to stop breastfeeding after vaccination. 

Pregnant women are not routinely recommended to have COVID-19 vaccination. They can consider vaccination:

  • if they are at higher risk of getting COVID-19, for example due to their occupation, or 
  • if they have risk factors for severe illness, for example due to pre-existing medical conditions. 

If you are pregnant, your healthcare provider can help you to assess the benefits and risks of vaccination. The Pfizer (Comirnaty) COVID-19 vaccine is preferred over the COVID-19 Vaccine AstraZeneca for pregnant women due to their age.

For more information on use of the vaccine in pregnancy and breastfeeding see: COVID-19 vaccination decision guide for women who are pregnant, breastfeeding or planning pregnancy. (https://www.health.gov.au/resources/publications/covid-19-vaccination-covid-19-vaccination-decision-guide-for-women-who-are-pregnant-breastfeeding-or-planning-pregnancy)

People with a history of COVID-19

If you have ever had COVID-19 in the past, tell your immunisation provider. Your provider may advise to wait for up to six months after recovery before having a COVID-19 vaccine. If you have ongoing illness from COVID-19, discuss the best timing of vaccination with your treating doctor. 

Either COVID-19 vaccine brand can be used in people with a past history of COVID-19

COVID-19 Vaccine AstraZeneca and children

COVID-19 Vaccine AstraZeneca has only been provisionally approved for use in people aged 18 years or older, and cannot be given to younger people. The risk of COVID-19, especially severe disease, in children is lower than in older adolescents and adults. 

Vaccine safety and reporting adverse events

The Therapeutic Goods Administration (TGA) assesses all vaccines in Australia. This ensures that in order for a vaccine to be approved it is safe, effective and manufactured to a very high quality standard. A description of the process for approval of COVID-19 vaccines is available on the TGA website. (https://www.tga.gov.au/covid-19-vaccine-approval-process )

The safety of COVID-19 vaccines will be monitored continuously throughout the COVID-19 vaccination program. Suspected side effects can be reported to your vaccination provider or other healthcare professional. They will then make a formal report on your behalf to your state or territory health department or directly to the Therapeutic Goods Administration (TGA).

If you would prefer to report it yourself, please visit the TGA website (https://www.tga.gov.au/reporting-suspected-side-effects-associated-covid-19-vaccine ) for information on how to report suspected side effects associated with COVID-19 vaccines.

Medical experts have studied COVID-19 vaccines to make sure they are safe. Most side effects are mild and don’t last for long. As with any vaccine or medicine, there may be rare and/or unknown side effects.

You can also tell your healthcare provider if you have any side effects like a sore arm, headache, fever or something else. If you have a side effect that worries you, please call your doctor.

Further information is detailed in these announcements

https://www.health.gov.au/news/joint-statement-on-covid-19-astrazeneca-vaccine-advice-from-atagi

https://www.tga.gov.au/media-release/astrazeneca-chadox1-s-covid-19-vaccine

People should discuss this information when considering the benefits and risks of COVID-19 vaccination with their usual doctor.

Some people may still get COVID-19 after vaccination. So you must still follow public health precautions as required in your state or territory to stop the spread of COVID-19 including:

  • keep your distance – stay at least 1.5 metres away from other people
  • washing your hands often with soap and water, or use hand sanitiser
  • wear a mask, if your state or territory has advised you should
  • stay home if you are unwell with cold or flu-like symptoms andarrange to get a COVID-19 test.Vaccination providers record all vaccinations on the Australian Immunisation Register, as required by Australian law. You can view your vaccination record online through your:
    • Medicare account
    • MyGov account
    • MyHealthRecord account.

Other Resources

We have compiled a list of resources so that you may explore aspects of the vaccine relevant to you.

AstraZeneca vaccine and the COVID-19 vaccination program – Patient information
https://www.health.gov.au/resources/publications/astrazeneca-vaccine-and-the-covid-19-vaccination-program-patient-information

Healthdirect COVID-19 Vaccination Information
https://www.healthdirect.gov.au/covid-19-vaccination

Department of Health COVID-19 Vaccine Website
https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines

COVID-19 vaccination – Easy Read resources
https://www.health.gov.au/resources/collections/covid-19-vaccination-easy-read-resources

COVID-19 Vaccines – How vaccines work
This video describes how vaccines work in the body after you receive a vaccination
https://www.health.gov.au/resources/videos/covid-19-vaccines-how-vaccines-work

COVID-19 Vaccines
News and information for Australians about the development, approval process and plans for COVID-19 vaccines.
https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines

Consumer Medical Information – AstraZeneca COVID-19 Vaccine
https://www.tga.gov.au/sites/default/files/cmi-approved-covid19-vaccine-az.pdf

TGA Information about the AstraZeneca Vaccine
https://www.tga.gov.au/covid-19-vaccine-astrazeneca-chadox1-s

COVID-19 vaccination – After your AstraZeneca vaccine
A patient fact sheet about what to expect after being given the COVID-19 AstraZeneca vaccination
https://www.health.gov.au/resources/publications/covid-19-vaccination-after-your-astrazeneca-vaccine

STEP 4 – Book Your Appointment

If you have completed all of the above steps then you are ready to book your appointment.

PLEASE DO NOT PHONE IF POSSIBLE – UTILISE THIS ONLINE BOOKING SERVICE

We are utilising our Appointuit booking system. Follow the steps as indicated in the booking web-app by clicking on the button below.

DO NOT ATTEND YOUR APPOINTMENT IF YOU:
  • HAVE BEEN IN CONTACT WITH A SUSPECTED CASE OF COVID-19 OR
  • ARE AWAITING FOR A COVID-19 SWAB RESULT OR
  • HAVE ANY OF THE FOLLOWING SYMPTOMS
    • SORE THROAT
    • FEVER
    • COUGH
    • RUNNY NOSE
    • SHORTNESS OF BREATH

You will be required to wait at least 15 minutes after your vaccination in order to ensure no immediate adverse reaction occurs.

NEW PATIENTS


If you are a new patient of the practice, you MUST bring your Medicare card along with a form of photo identification. If you have pre-existing illnesses or allergies, a health summary from your usual medical practitioner is also recommended.

Please arrive at least 20 minutes before your appointment to allow time for registration to be completed. Our registration form may be downloaded HERE so that you may fill it in before your attendance.

During Phase 1b of the vaccine rollout, we will require some documentation from our new patients depending on your eligibility. Examples are shown in this table:

Healthcare Workers not included in Phase 1aProof of occupation (ID card, letter from employer) or Phase 1B Declaration Form
Critical and high risk workersProof of occupation (ID card, letter from employer) or Phase 1B Declaration Form
People over 70 yearsAll standard forms of identification (drivers licence, passport) will be accepted
Aboriginal and Torres Strait Islanders over 55 yearsSelf-identification as an Aboriginal and/or Torres Strait Islander Person
People over 18 years with an underlying medical condition, including disabilityMedical records (for example, a clinic record, MyHealth Record, printout of chronic disease plan); a referral from a GP or treating specialist; or a Phase 1B Declaration Form
Carers and disability workersCarers documentation or
proof of occupation (ID card or letter from employer/centre-based support provider); or a Phase 1B Declaration Form

WHEN BOOKING YOU APPOINTMENT PLEASE NOTE THAT WE HAVE SEVERAL VACCINATORS FOR EACH OF OUR BRANCHES.

IF YOU CANNOT FIND AN APPOINTMENT WITH ONE VACCINATOR, THEN TRY ANOTHER ONE.

WE SUGGEST THAT YOU DO NOT USE “NEXT AVAILABLE APPOINTMENT” AS THIS WILL RESTRICT YOUR OPTIONS FOR CHOOSING AN APPROPRIATE DATE.

STEP 5 – After Your Vaccination

After waiting for 15 minutes, you are free to leave the premises provided there are no immediate side effects.

You will need to schedule an appointment for your SECOND COVID-19 vaccine dose at approximately 12 weeks from your first.

An up-to-date information handout may be found at this link:

https://www.health.gov.au/resources/publications/covid-19-vaccination-after-your-astrazeneca-vaccine

Vaccine Side effects

As with any vaccine, you may have some side effects after receiving a COVID-19 vaccine. 

Common side effects after COVID-19 Vaccine AstraZeneca include:

  • pain, swelling, tenderness, redness or itching at the injection site
  • tiredness
  • headache
  • muscle pain
  • nausea
  • fever and chills
  • feeling unwell
  • joint pain.

Less common side effects after COVID-19 Vaccine AstraZeneca include:

  • enlarged lymph nodes
  • pain in limb
  • dizziness
  • decreased appetite
  • stomach pain

These side effects are usually mild and usually go away within one or two days. Some recipients will experience more significant flu-like symptoms from this vaccination compared to other common vaccinations and may require time away from normal activities. These symptoms may occur after either the first or second dose but are more common after the first dose.

If you experience pain at the injection site or fever, headaches or body aches after vaccination, you can take paracetamol or ibuprofen. These help to reduce some of the above symptoms. You do not need to take paracetamol or ibuprofen before vaccination. If there is swelling at the injection site, you can use a cold compress.

Rare side effects that have been reported after COVID-19 Vaccine AstraZeneca are:

  • Severe allergic reaction (anaphylaxis):
    • This occurs in approximately 1 in a million people getting this vaccine.
  • A very rare and unusual clotting condition:
    • A very rare side effect of an unusual condition involving blood clotting and low blood platelet count may occur after of the AstraZeneca COVID-19 vaccine. This affects approximately 4 to 6 out of a million people after receiving a first dose, but has not been seen after the second dose of this vaccine.
    • The blood clots can occur at different parts of the body, including the brain (this is called cerebral venous sinus thrombosis) and the abdomen. The low level of blood platelets can cause bleeding. 
    • The symptoms of this condition mostly start between 4 and 20 days after vaccination. 
    • People with this condition get very unwell and need to go to hospital. This condition can lead to long-term disability, and even death.

You should seek medical attention after vaccination if:

  • You think you are having an allergic reaction. Call 000 if you experience severe symptoms, such as difficulty breathing, wheezing, a fast heartbeat or collapsing.
  • You have an expected side effect of the vaccine which has not gone away after a few days.
  • You have :
    • severe, persistent headaches that are different to your “usual” headaches and do not settle with paracetamol or other painkillers
    • blurred vision
    • weakness of face or limbs
    • confusion or seizure.
  • You are worried about a potential side effect or have new or unexpected symptoms, particularly in the 4–20 days after vaccination, such as:
    • shortness of breath
    • chest pain
    • persistent abdominal pain
    • leg swelling
    • pin-prick rash or bruising not at the injection site that cannot be explained.

Be sure to tell your doctor that you have recently received the vaccine. For symptoms which are not urgent, you can see your regular healthcare provider (usually your GP).

Serious reactions such as allergic reactions are extremely rare. They usually occur within 15 minutes of receiving a vaccine. After you receive your vaccine, you should wait this amount of time before you leave to ensure your safety in case a reaction occurs.

Use the COVID-19 vaccine side effects symptom checker if you have concerns about any symptoms after your vaccine. The checker is also available through the National Coronavirus Helpline, 1800 020 080, 24 hours a day.

More information may be found at this link:
https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/learn-about-covid-19-vaccines/what-happens-after-i-am-vaccinated-for-covid-19

If you believe that you may have a side effect, you may report this directly to the TGA. More information regarding reporting is found at these links

  • Victorian Surveillance of Adverse Effects following Vaccination in the Community ( SAEFVIC)
    https://www.safevac.org.au/Home/Info/VIC
  • Report directly to the TGA (Therapeutic Goods Administration)
    https://www.tga.gov.au/reporting-problems
  • Report to the NPS MedicineWise Adverse Medicine Events line
    Consumers can make a report and obtain advice from a pharmacist by calling the NPS MedicineWise Adverse Medicine Events line on 1300 134 237 (8am-8pm seven days a week)
AusVaxSafety’s ACTIVE follow-up after your COVID-19 vaccination

What is AusVaxSafety?

AusVaxSafety is a national system for monitoring vaccine safety in Australia. The system is led by the National Centre for Immunisation Research and Surveillance (NCIRS). It is funded by the Australian Government Department of Health.

AusVaxSafety monitoring vaccine safety of COVID-19 vaccines

In partnership with the Australian state and territory health departments, AusVaxSafety is following up people who receive a COVID-19 vaccine by sending them an SMS or email with a short survey that asks if they experienced any adverse event following vaccination.

How does it work?

These surveys give you the opportunity to report any adverse events you have after receiving the COVID-19 vaccine. Depending on your survey responses, your state/territory health department or immunisation provider may call you to collect more details.

What happens to the information you provide?

Survey responses will contribute to the national COVID-19 vaccine safety surveillance that AusVaxSafety is conducting.

What about your personal data?

AusVaxSafety only receives responses that are ‘de-identified’ to protect your privacy. This means any information that could identify you or your child will be removed.

COVID-19 testing after vaccination

Some side effects from COVID-19 vaccination might be similar to symptoms of COVID-19 
(e.g. fever). However, COVID-19 Vaccine AstraZeneca does not contain any live SARS-CoV-2 virus and cannot cause COVID-19. You may notneed to get a COVID-19 test or isolate:

  • if you develop general symptoms like fever, headache or tiredness in the first two days after vaccination, and 
  • if you are sure that you don’t have any respiratory symptoms (e.g. runny nose, cough, sore throat, loss of smell or loss of taste). 

However, you should check the current guidelines in your state/territory for the most up-to-date information. This advice may change in the event of a COVID-19 outbreak in your local area. You may still need to get a COVID-19 test if you meet other criteria, for example if you are a close contact of a known COVID-19 case. If in doubt, seek medical assessment.

error: Content is protected !!